AcquisitionOther
Avere Therapeutics (via merger) acquired NextCure, Inc.
Public M&A record from 8-K. The source names the buyer and target, and terms are shown only when the filing or announcement discloses them.
Deal tape row
Avere Therapeutics (via merger) -> NextCure, Inc. · $320 million
Combine Avere's differentiated oral IL-23 program with NextCure's public market infrastructure.
Open source record (SEC) ↗